The FLOTILLA Study is a clinical trial for people who took part in earlier trials using two medicines called encorafenib and binimetinib. These medicines are used to treat certain types of cancer. This study lets participants continue using these medicines if they are benefiting from them, as determined by their study doctor. Only those who were in past studies with these medicines can join. Participants will take the same doses as before for up to 5 years.
- Participants must have been in an earlier study and still benefit from the medicines.
- The study lasts up to 5 years and uses the same medicine doses as before.
- Cannot join if you had stopped treatment in a previous study or have serious side effects.